-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Nika Pharmaceuticals, Inc quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q2 2024.
- Nika Pharmaceuticals, Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$8.37K, a 17.5% increase year-over-year.
- Nika Pharmaceuticals, Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$109K, a 71.8% decline year-over-year.
- Nika Pharmaceuticals, Inc annual Operating Income (Loss) for 2023 was -$64.8K, a 98% increase from 2022.
- Nika Pharmaceuticals, Inc annual Operating Income (Loss) for 2022 was -$3.18M, a 21540% decline from 2021.
- Nika Pharmaceuticals, Inc annual Operating Income (Loss) for 2021 was -$14.7K, a 65.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)